The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Huntington's Disease Therapeutics Market Research Report 2025
Synopsis
Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease.
The global Huntington's Disease Therapeutics market was valued at US$ 227.3 million in 2023 and is anticipated to reach US$ 1433.7 million by 2030, witnessing a CAGR of 29.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Huntington's Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Huntington's Disease Therapeutics.
Report Scope
The Huntington's Disease Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Huntington's Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Huntington's Disease Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche
H. Lundbeck
Prana Biotechnology
Teva Pharmaceutical Industries
Horizon Pharma
Segment by Type
Antidopaminergics
Anticonvulsants
Antipsychotics
Antidepressants
Segment by Application
Hospitals
Clinics
Diagnostic Centers
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Huntington's Disease Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Huntington's Disease Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease.
The global Huntington's Disease Therapeutics market was valued at US$ 227.3 million in 2023 and is anticipated to reach US$ 1433.7 million by 2030, witnessing a CAGR of 29.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Huntington's Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Huntington's Disease Therapeutics.
Report Scope
The Huntington's Disease Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Huntington's Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Huntington's Disease Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche
H. Lundbeck
Prana Biotechnology
Teva Pharmaceutical Industries
Horizon Pharma
Segment by Type
Antidopaminergics
Anticonvulsants
Antipsychotics
Antidepressants
Segment by Application
Hospitals
Clinics
Diagnostic Centers
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Huntington's Disease Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Huntington's Disease Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Huntington's Disease Therapeutics Market Overview
1.1 Product Overview and Scope of Huntington's Disease Therapeutics
1.2 Huntington's Disease Therapeutics Segment by Type
1.2.1 Global Huntington's Disease Therapeutics Market Value Comparison by Type (2024-2030)
1.2.2 Antidopaminergics
1.2.3 Anticonvulsants
1.2.4 Antipsychotics
1.2.5 Antidepressants
1.3 Huntington's Disease Therapeutics Segment by Application
1.3.1 Global Huntington's Disease Therapeutics Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.4 Global Huntington's Disease Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Huntington's Disease Therapeutics Revenue 2019-2030
1.4.2 Global Huntington's Disease Therapeutics Sales 2019-2030
1.4.3 Global Huntington's Disease Therapeutics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Huntington's Disease Therapeutics Market Competition by Manufacturers
2.1 Global Huntington's Disease Therapeutics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Huntington's Disease Therapeutics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Huntington's Disease Therapeutics Average Price by Manufacturers (2019-2024)
2.4 Global Huntington's Disease Therapeutics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Huntington's Disease Therapeutics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Huntington's Disease Therapeutics, Product Type & Application
2.7 Huntington's Disease Therapeutics Market Competitive Situation and Trends
2.7.1 Huntington's Disease Therapeutics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Huntington's Disease Therapeutics Players Market Share by Revenue
2.7.3 Global Huntington's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Huntington's Disease Therapeutics Retrospective Market Scenario by Region
3.1 Global Huntington's Disease Therapeutics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Huntington's Disease Therapeutics Global Huntington's Disease Therapeutics Sales by Region: 2019-2030
3.2.1 Global Huntington's Disease Therapeutics Sales by Region: 2019-2024
3.2.2 Global Huntington's Disease Therapeutics Sales by Region: 2025-2030
3.3 Global Huntington's Disease Therapeutics Global Huntington's Disease Therapeutics Revenue by Region: 2019-2030
3.3.1 Global Huntington's Disease Therapeutics Revenue by Region: 2019-2024
3.3.2 Global Huntington's Disease Therapeutics Revenue by Region: 2025-2030
3.4 North America Huntington's Disease Therapeutics Market Facts & Figures by Country
3.4.1 North America Huntington's Disease Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Huntington's Disease Therapeutics Sales by Country (2019-2030)
3.4.3 North America Huntington's Disease Therapeutics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Huntington's Disease Therapeutics Market Facts & Figures by Country
3.5.1 Europe Huntington's Disease Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Huntington's Disease Therapeutics Sales by Country (2019-2030)
3.5.3 Europe Huntington's Disease Therapeutics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Huntington's Disease Therapeutics Market Facts & Figures by Country
3.6.1 Asia Pacific Huntington's Disease Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Huntington's Disease Therapeutics Sales by Country (2019-2030)
3.6.3 Asia Pacific Huntington's Disease Therapeutics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Huntington's Disease Therapeutics Market Facts & Figures by Country
3.7.1 Latin America Huntington's Disease Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Huntington's Disease Therapeutics Sales by Country (2019-2030)
3.7.3 Latin America Huntington's Disease Therapeutics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Huntington's Disease Therapeutics Market Facts & Figures by Country
3.8.1 Middle East and Africa Huntington's Disease Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Huntington's Disease Therapeutics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Huntington's Disease Therapeutics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Huntington's Disease Therapeutics Sales by Type (2019-2030)
4.1.1 Global Huntington's Disease Therapeutics Sales by Type (2019-2024)
4.1.2 Global Huntington's Disease Therapeutics Sales by Type (2025-2030)
4.1.3 Global Huntington's Disease Therapeutics Sales Market Share by Type (2019-2030)
4.2 Global Huntington's Disease Therapeutics Revenue by Type (2019-2030)
4.2.1 Global Huntington's Disease Therapeutics Revenue by Type (2019-2024)
4.2.2 Global Huntington's Disease Therapeutics Revenue by Type (2025-2030)
4.2.3 Global Huntington's Disease Therapeutics Revenue Market Share by Type (2019-2030)
4.3 Global Huntington's Disease Therapeutics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Huntington's Disease Therapeutics Sales by Application (2019-2030)
5.1.1 Global Huntington's Disease Therapeutics Sales by Application (2019-2024)
5.1.2 Global Huntington's Disease Therapeutics Sales by Application (2025-2030)
5.1.3 Global Huntington's Disease Therapeutics Sales Market Share by Application (2019-2030)
5.2 Global Huntington's Disease Therapeutics Revenue by Application (2019-2030)
5.2.1 Global Huntington's Disease Therapeutics Revenue by Application (2019-2024)
5.2.2 Global Huntington's Disease Therapeutics Revenue by Application (2025-2030)
5.2.3 Global Huntington's Disease Therapeutics Revenue Market Share by Application (2019-2030)
5.3 Global Huntington's Disease Therapeutics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 F. Hoffmann-La Roche
6.1.1 F. Hoffmann-La Roche Corporation Information
6.1.2 F. Hoffmann-La Roche Description and Business Overview
6.1.3 F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 F. Hoffmann-La Roche Huntington's Disease Therapeutics Product Portfolio
6.1.5 F. Hoffmann-La Roche Recent Developments/Updates
6.2 H. Lundbeck
6.2.1 H. Lundbeck Corporation Information
6.2.2 H. Lundbeck Description and Business Overview
6.2.3 H. Lundbeck Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 H. Lundbeck Huntington's Disease Therapeutics Product Portfolio
6.2.5 H. Lundbeck Recent Developments/Updates
6.3 Prana Biotechnology
6.3.1 Prana Biotechnology Corporation Information
6.3.2 Prana Biotechnology Description and Business Overview
6.3.3 Prana Biotechnology Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Prana Biotechnology Huntington's Disease Therapeutics Product Portfolio
6.3.5 Prana Biotechnology Recent Developments/Updates
6.4 Teva Pharmaceutical Industries
6.4.1 Teva Pharmaceutical Industries Corporation Information
6.4.2 Teva Pharmaceutical Industries Description and Business Overview
6.4.3 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Product Portfolio
6.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.5 Horizon Pharma
6.5.1 Horizon Pharma Corporation Information
6.5.2 Horizon Pharma Description and Business Overview
6.5.3 Horizon Pharma Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Horizon Pharma Huntington's Disease Therapeutics Product Portfolio
6.5.5 Horizon Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Huntington's Disease Therapeutics Industry Chain Analysis
7.2 Huntington's Disease Therapeutics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Huntington's Disease Therapeutics Production Mode & Process
7.4 Huntington's Disease Therapeutics Sales and Marketing
7.4.1 Huntington's Disease Therapeutics Sales Channels
7.4.2 Huntington's Disease Therapeutics Distributors
7.5 Huntington's Disease Therapeutics Customers
8 Huntington's Disease Therapeutics Market Dynamics
8.1 Huntington's Disease Therapeutics Industry Trends
8.2 Huntington's Disease Therapeutics Market Drivers
8.3 Huntington's Disease Therapeutics Market Challenges
8.4 Huntington's Disease Therapeutics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
